Uchino S, Bellomo R, Kellum J A, Morimatsu H, Morgera S, Schetz M R, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-Van Straaten H M, Ronco C
Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, Tokyo - Japan.
Int J Artif Organs. 2007 Apr;30(4):281-92. doi: 10.1177/039139880703000402.
Using a large, international cohort, we sought to determine the effect of initial technique of renal replacement therapy (RRT) on the outcome of acute renal failure (ARF) in the intensive care unit (ICU). We enrolled 1218 patients treated with continuous RRT (CRRT) or intermittent RRT (IRRT) for ARF in 54 ICUs in 23 countries. We obtained demographic, biochemical and clinical data and followed patients to either death or hospital discharge. Information was analyzed to assess the independent impact of treatment choice on survival and renal recovery. Patients treated first with CRRT (N=1006, 82.6%) required vasopressor drugs and mechanical ventilation more frequently compared to those receiving IRRT (N=212, 17.4%), (p<0.0001). Unadjusted hospital survival was lower (35.8% vs. 51.9%, p<0.0001). However, unadjusted dialysis-independence at hospital discharge was higher after CRRT (85.5% vs. 66.2%, p<0.0001). Multivariable logistic regression showed that choice of CRRT was not an independent predictor of hospital survival or dialysis-free hospital survival. However, the choice of CRRT was a predictor of dialysis independence at hospital discharge among survivors (OR: 3.333, 95% CI: 1.845 - 6.024, p<0.0001). Further adjustment using a propensity score did not significantly change these results. We conclude that worldwide, the choice of CRRT as initial therapy is not a predictor of hospital survival or dialysis-free hospital survival but is an independent predictor of renal recovery among survivors.
我们利用一个大型国际队列,试图确定肾脏替代治疗(RRT)的初始技术对重症监护病房(ICU)中急性肾衰竭(ARF)患者预后的影响。我们纳入了在23个国家54个ICU中接受连续性RRT(CRRT)或间歇性RRT(IRRT)治疗ARF的1218例患者。我们获取了人口统计学、生化和临床数据,并对患者进行随访直至死亡或出院。对信息进行分析,以评估治疗选择对生存和肾功能恢复的独立影响。与接受IRRT的患者(n = 212,17.4%)相比,首先接受CRRT治疗的患者(n = 1006,82.6%)更频繁地需要血管活性药物和机械通气(p<0.0001)。未经调整的住院生存率较低(35.8%对51.9%,p<0.0001)。然而,CRRT后出院时未调整的无需透析率较高(85.5%对66.2%,p<0.0001)。多变量逻辑回归显示,选择CRRT并非住院生存或无透析住院生存的独立预测因素。然而,选择CRRT是幸存者出院时无需透析的预测因素(比值比:3.333,95%置信区间:1.845 - 6.024,p<0.0001)。使用倾向评分进行进一步调整并未显著改变这些结果。我们得出结论,在全球范围内,选择CRRT作为初始治疗并非住院生存或无透析住院生存的预测因素,但却是幸存者肾功能恢复的独立预测因素。